Serum 25-Hydroxyvitamin D Deficiency in Ischemic Stroke and Subtypes in Indian Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Vitamin D deficiency is common across all age groups and may contribute to cardiovascular diseases. Serum 25-hydroxyvitamin D deficiency causing ischemic stroke has been documented in recent reports. Aim To investigate the association of serum 25-hydroxyvitamin D deficiency with ischemic stroke and subtypes. Methods We recruited 250 consecutive ischemic stroke patients and 250 age and sex matched controls attending the Department of Neurology, at Yashoda hospital, Hyderabad, India, from January 2011 to December 2012. All ischemic stroke patients underwent stroke subtyping. We measured 25-hydroxyvitamin D by chemiluminescence test, serum calcium, phosphorus, alkaline phosphatase, and C-reactive protein (CRP) in cases and controls. Results Out of 250 stroke patients, 190 (76%) were men and mean age was 58.4±11.1 years (age range-26-89 years). 25-hydroxyvitamin D deficiency was observed in 122 (48.8%) stroke patients and 79 (31.6%) controls (P=0.001). Among stroke patients, serum 25-hydroxyvitamin D deficiency was found in 54.9% (50/91) of patients with large artery atherosclerosis, 54% (20/37) in cardioembolic stroke, 44.4% (20/45) in small artery diseases, 42.8% (15/35) in stroke of other determined etiology and 40.4% (17/42) in stroke of un-determined etiology. Multiple logistic regression analysis showed an independent association of 25-hydroxyvitamin D deficiency with ischemic stroke (odds ratio: 1.6; 95% CI 1.2-2.8). The association was strongest with large artery atherosclerosis (odds ratio: 2.4; 95% CI 1.6-3.5) and cardioembolic stroke (odds ratio: 2.0; 95% CI 1.0-3.2). Conclusions We found that 25-hydroxyvitamin D deficiency had an independent association with ischemic stroke. The association was established in large artery arthrosclerosis and cardioembolic stroke.
Abstract
Background and Purpose Vitamin D deficiency is common across all age groups and may contribute to cardiovascular diseases. Serum 25-hydroxyvitamin D deficiency causing ischemic stroke has been documented in recent reports. Aim To investigate the association of serum 25-hydroxyvitamin D deficiency with ischemic stroke and subtypes. Methods We recruited 250 consecutive ischemic stroke patients and 250 age and sex matched controls attending the Department of Neurology, at Yashoda hospital, Hyderabad, India, from January 2011 to December 2012. All ischemic stroke patients underwent stroke subtyping. We measured 25-hydroxyvitamin D by chemiluminescence test, serum calcium, phosphorus, alkaline phosphatase, and C-reactive protein (CRP) in cases and controls. Results Out of 250 stroke patients, 190 (76%) were men and mean age was 58.4±11.1 years (age range-26-89 years). 25-hydroxyvitamin D deficiency was observed in 122 (48.8%) stroke patients and 79 (31.6%) controls (P=0.001). Among stroke patients, serum 25-hydroxyvitamin D deficiency was found in 54.9% (50/91) of patients with large artery atherosclerosis, 54% (20/37) in cardioembolic stroke, 44.4% (20/45) in small artery diseases, 42.8% (15/35) in stroke of other determined etiology and 40.4% (17/42) in stroke of un-determined etiology. Multiple logistic regression analysis showed an independent association of 25-hydroxyvitamin D deficiency with ischemic stroke (odds ratio: 1.6; 95% CI 1.2-2.8). The association was strongest with large artery atherosclerosis (odds ratio: 2.4; 95% CI 1.6-3.5) and cardioembolic stroke (odds ratio: 2.0; 95% CI 1.0-3.2). Conclusions We found that 25-hydroxyvitamin D deficiency had an independent association with ischemic stroke. The association was established in large artery arthrosclerosis and cardioembolic stroke.
참고문헌 (52)
- Biswas M., "Etiology and risk factors of ischemic stroke in Indian American patients from a hospital based registry in New Jersey USA", Neurol Asia, 14, pp.81~86 (2009)
- Pilz S., "Low vitamin D levels predict stroke in patients referred to coronary angiography", Stroke, 39, pp.2611~2613 (2008)
- Kilkkinen A., "Vitamin D status and the risk of cardiovascular disease death", Am J Epidemiol, 170, pp.1032~1039 (2009)
- Zhao G., "Serum 25-hydroxy vitamin levels and all-cause and cardiovascular disease mortality among US adults with hypertension; the NHANES linked mortality study", J Hypertens, 30, pp.284~289 (2012)
- Kendrick J., "25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey", Atherosclerosis, 205, pp.255~260 (2009)
- Pasco JA., "Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption and fractures : the Geelong Osteoporosis Study", J Bone Miner Res, 19, pp.752~758 (2004)
- Ono Y., "Seasonal changes of serum 25-hydroxy vitamin D and intact parathyroid hormone levels in a normal Japanese population", J Bone Miner Metab, 23, pp.147~151 (2005)
- Mallah EM., "Plasma concentrations of 25-hydroxyvitamin D among Jordanians : effect of biological and habitual factors on vitamin D status", BMC Clin Pathol, 11, pp.8~ (2011)
- Attia A., "Therapeutic potential of 25-hydroxy vitamin D in promoting cardiovascular Health", Arab J of Nephrol and Transplant, 3, pp.37~46 (2010)
- Holick MF., "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)
- Harinarayan CV., "High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians", Am J Clin Nutr, 85, pp.1062~1067 (2007)
- Tharvaldsen P, "Monitoring Trends and Determinants in Cardiovascular disease Vol 26", pp.361~370 (1995), World Health Organization
- Adams JrHP., "Classification of Subtypes of Acute Ischemic stroke Definitions for use in a multicenter clinical trial TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~34 (1993)
- Gentry EM., "The Behavioral Risk factor Surveys, II : design, methods and estimates from combined state data", Am J Prev Med, 1, pp.9~14 (1985)
- Britov AN., "New guidelines of Joint National Committee(USA)on prevention, Diagnosis and Management of Hypertension", From JNC VI to JNC VII Kardiologiia, 43, pp.93~97 (2003)
- Kuzuyz T., "Report of the Committee on the classification and diagnostic criteria of diabetes mellitus", Diabetes Res Clin Pract, 55, pp.65~85 (2002)
- Radhakrishnamurthy B., "Blood Lipid: In Heart Disease", pp.18~27 (2003), Quill publication
- Glader CA., "The proatherogenic properties of lipoprotein(a)may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae specific IgG antibodies", Eur Heart J, 21, pp.639~646 (2000)
- Saponsik G., "Differences in stroke subtypes among natives and Caucasians in Boston and Buenos Aires", Stroke, 31, pp.2385~2389 (2000)
- Radhakrishnamurthy B, "Obesity: In Heart Disease", pp.38~44 (2003), Quill publication
- Nemerovski CW., "Vitamin D and cardiovascular disease", Pharmacotherapy, 29, pp.691~708 (2009)
- Lee JH., "Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?", J Am Coll Cardiol, 52, pp.1949~1956 (2008)
- Poole KE., "Reduced vitamin D in acute stroke", Stroke, 37, pp.243~245 (2006)
- Sun Q., "25-Hydroxyvitamin D levels and the risk of stroke : a prospective study and meta-analysis", Stroke, 43, pp.1470~1477 (2012)
- Buell JS., "25 Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services", Neurology, 74, pp.18~26 (2010)
- Bonakdaran S., "Correlation between serum 25-hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients", Saudi Med J, 30, pp.509~514 (2009)
- Carrelli AL., "Vitamin D deficiency is associated with subclinical carotid atherosclerosis : the Northern Manhattan study", Stroke, 42, pp.2240~2245 (2011)
- Martins D., "Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States : data from the Third National Health and Nutrition Examination Survey", Arch Intern Med, 167, pp.1159~1165 (2007)
- Zittermann A., "Low vitamin D status : a contributing factor in the pathogenesis of congestive heart failure?", J Am Coll Cardiol, 41, pp.105~112 (2003)
- Kim DH., "Prevalence of hypovitaminosis D in cardiovascular diseases(from the National Health and Nutrition Examination Survey 2001 to 2004)", Am J Cardiol, 102, pp.1540~1544 (2008)
- Giovannucci E., "25-hydroxyvitamin D and risk of myocardial infarction in men : a prospective study", Arch Intern Med, 168, pp.1174~1180 (2008)
- de Boer IH., "25-hydroxyvitamin D levels inversely associated with risk for developing coronary artery calcification", J Am Soc Nephrol, 20, pp.1805~1812 (2009)
- Michos ED., "Vitamin D and cardiovascular disease risk", Curr Opin Clin Nutr Metab Care, 11, pp.7~12 (2008)
- Marcén R., "Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation", Nephrol Dial Transplant, 27(Suppl 4), pp.iv47~iv52 (2012)
- Kühn T., "Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study", PLoS One, 8, pp.e69080~ (2013)
- Li YC., "1, 25-Dihydroxyvitamin D(3)is a negative endocrine regulator of the renin-angiotensin system", J Clin Invest, 110, pp.229~238 (2002)
- Aihara K., "Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice", J Biol Chem, 279, pp.35798~35802 (2004)
- Watson KE., "Active serum vitamin D levels are inversely correlated with coronary calcification", Circulation, 96, pp.1755~1760 (1997)
- Merke J., "Demonstration of 1, 25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro", Calcif Tissue Int, 41, pp.112~114 (1987)
- Rigby WF., "Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA", J Clin Invest, 79, pp.1659~1664 (1987)
- Jouni ZE., "1, 25-Dihydroxyvitamin D3-induced HL-60 macrophages : regulation of cholesterol and LDL metabolism", Atherosclerosis, 117, pp.125~138 (1995)
- Nisbet JA., "Detection of osteomalacia in British Asians : a comparison of clinical score with biochemical measurements", Clin Sci, 78, pp.383~389 (1990)
- Preece MA., "Vitamin D deficiency among Asian immigrants to Britain", Lancet, 1, pp.907~910 (1973)
- Holick MF., "Primer on the Metabolic Bone Diseases, 4th edn", pp.92~99 (1999), Lippincott Williams and Wilkins
- Lips P., "Vitamin D deficiency and secondary hyperparathyroidism in the elderly : consequences for bone loss and fractures and therapeutic implications", Endocrine Rev, 22, pp.477~501 (2001)
- Ryu WS, "Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke", Neurology, 30(75), pp.1995~2002 (2010)
- den Hertog HM., "C-reactive protein in the very early phase of acute ischemic stroke : association with poor outcome and death", J Neurol, 256, pp.2003~2008 (2009)
- Di Napoli M., "C-reactive protein in ischemic stroke : an independent prognostic factor", Stroke, 32, pp.917~924 (2001)
- Gillor A., "Congestive heart failure in rickets caused by vitamin D deficiency", Monatsschr Kinderheilk, 137, pp.108~110 (1989)
- MacLaughlin J., "Aging decreases the capacity of human skin to produce vitamin D3", J Clin Invest, 76, pp.1536~1538 (1985)
- Jain V., "Vitamin D deficiency in healthy breastfed term infants at 3 months & their mothers in India : seasonal variation & determinants", Indian J Med Res, 133, pp.267~273 (2011)
- Goswami R., "Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi", Am J Clin Nutr, 72, pp.472~475 (2000)
